Caterina Torrisi

Structure–Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and <i>in Vivo</i> Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers

Romain Siegrist, Davide Pozzi, Gaël Jacob et al. · Journal of Medicinal Chemistry · 2016 · 30 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Identification of a series of 4-[3-(quinolin-2-yl)-1,2,4-oxadiazol-5-yl]piperazinyl ureas as potent smoothened antagonist hedgehog pathway inhibitors

Jesus M. Ontoria, Laura Llauger Bufi, Caterina Torrisi et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists

Ester Muraglia, Jesus M. Ontoria, Danila Branca et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 25 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +4

Identification and SAR of novel pyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1)

Giovanna Pescatore, Danila Branca, Fabrizio Fiore et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 21 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells

Federica Ferrigno, Danila Branca, Olaf Kinzel et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 16 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +14